The β-secretase enzyme BACE1 as a therapeutic target for Alzheimer's disease

被引:0
|
作者
Robert Vassar
Patty C Kandalepas
机构
[1] Feinberg School of Medicine,Department of Cell & Molecular Biology
[2] Northwestern University,undefined
关键词
Amyloid Precursor Protein; Aspartic Protease; Nonpeptidic Compound; Amyloid Precursor Protein Substrate; Amyloid Precursor Protein Transgenics;
D O I
暂无
中图分类号
学科分类号
摘要
Amyloid plaques are defining histopathologic lesions in the brains of Alzheimer's disease (AD) patients and are composed of the amyloid-beta peptide, which is widely considered to play a critical role in the pathogenesis of AD. The β-secretase, or β-site amyloid precursor protein cleaving enzyme 1 (BACE1; also called Asp2, memapsin 2), is the enzyme that initiates the generation of amyloid beta. Consequently, BACE1 is an attractive drug target for lowering cerebral levels of amyloid beta for the treatment or prevention of AD. Much has been learned about BACE1 since its discovery over 10 years ago. In the present article, we review BACE1 properties and characteristics, cell biology, in vivo validation, substrates, therapeutic potential, and inhibitor drug development. Studies relating to the physiological functions of BACE1 and the promise of BACE1 inhibition for AD will also be discussed. We conclude that therapeutic inhibition of BACE1 should be efficacious for AD, although careful titration of the drug dose may be necessary to limit mechanism-based side effects.
引用
收藏
相关论文
共 50 条
  • [1] The β-secretase enzyme BACE1 as a therapeutic target for Alzheimer's disease
    Vassar, Robert
    Kandalepas, Patty C.
    [J]. ALZHEIMERS RESEARCH & THERAPY, 2011, 3 (03)
  • [2] The Alzheimer's disease β-secretase enzyme, BACE1
    Cole, Sarah L.
    Vassar, Robert
    [J]. MOLECULAR NEURODEGENERATION, 2007, 2 (1)
  • [3] The Alzheimer's disease β-secretase enzyme, BACE1
    Sarah L Cole
    Robert Vassar
    [J]. Molecular Neurodegeneration, 2
  • [4] BACE1 -: The β-secretase enzyme in Alzheimer's disease
    Vassar, R
    [J]. JOURNAL OF MOLECULAR NEUROSCIENCE, 2004, 23 (1-2) : 105 - 113
  • [5] The β-Secretase BACE1 in Alzheimer's Disease
    Hampel, Harald
    Vassar, Robert
    De Strooper, Bart
    Hardy, John
    Willem, Michael
    Singh, Neeraj
    Zhou, John
    Yan, Riqiang
    Vanmechelen, Eugeen
    De Vos, Ann
    Nistico, Robert
    Corbo, Massimo
    Imbimbo, Bruno Pietro
    Streffer, Johannes
    Voytyuk, Iryna
    Timmers, Maarten
    Monfared, Amir Abbas Tahami
    Irizarry, Michael
    Albala, Bruce
    Koyama, Akihiko
    Watanabe, Naoto
    Kimura, Teiji
    Yarenis, Lisa
    Lista, Simone
    Kramer, Lynn
    Vergallo, Andrea
    [J]. BIOLOGICAL PSYCHIATRY, 2021, 89 (08) : 745 - 756
  • [6] The β-Secretase Enzyme BACE1: A Biochemical Enigma for Alzheimer's Disease
    Shah, Hirak
    Patel, Ashish
    Parikh, Vruti
    Nagani, Afzal
    Bhimani, Bhargav
    Shah, Umang
    Bambharoliya, Tushar
    [J]. CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2020, 19 (03) : 184 - 194
  • [7] The Alzheimer's disease β-secretase (BACE1) is not a neuron-specific enzyme
    Rossner, S
    Hartlage-Rübsamen, M
    Lange-Dohna, C
    Zeitschel, U
    Bigl, V
    [J]. JOURNAL OF NEUROCHEMISTRY, 2003, 85 : 98 - 98
  • [8] BACE1, the Alzheimer’s beta-secretase enzyme, in health and disease
    Robert Vassar
    [J]. Molecular Neurodegeneration, 8 (Suppl 1)
  • [9] BACE1, the Alzheimer's beta-secretase enzyme, in health and disease
    Robert Vassar
    [J]. Molecular Neurodegeneration, 7 (Suppl 1)
  • [10] Alzheimer's disease β-secretase BACE1 is not a neuron-specific enzyme
    Rossner, S
    Lange-Dohna, C
    Zeitschel, U
    Perez-Polo, JR
    [J]. JOURNAL OF NEUROCHEMISTRY, 2005, 92 (02) : 226 - 234